Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Apellis Pharmaceuticals Inc (NQ: APLS)
43.04 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 5:48 PM EST, Jan 21, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 43.04
Bid (Size) 40.00 (4)
Ask (Size) 45.00 (2)
Prev. Close 43.04
Today's Range 43.04 - 43.04
52wk Range 12.50 - 43.14
Shares Outstanding 55,941,896
Dividend Yield N/A
Performance
YTD
+38.10%
+38.10%
1 Month
+50.65%
+50.65%
3 Month
+54.04%
+54.04%
6 Month
+52.19%
+52.19%
1 Year
+220.24%
+220.24%
Top News
More News
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
from GlobeNewswire News Releases
More News
Read More
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
from GlobeNewswire News Releases
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
from GlobeNewswire News Releases
Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
from GlobeNewswire News Releases
UPDATE 1-Blackstone raises three-quarters of targeted $4.6 bln life sciences fund
category companyNews
from Reuters: Company News
8 Stocks To Watch For January 8, 2020
category News , Market News , ATEN , and 16 more.
from Benzinga
Mid-Day Market Update: Crude Oil Down Over 1%; Cellect Biotechnology Shares Spike Higher
category PIR , Markets , CTIB , and 14 more.
from Benzinga
UPDATE 2-Apellis' drug better than Soliris in improving hemoglobin levels in trial
category companyNews
from Reuters: Company News
Mid-Morning Market Update: Markets Mixed; Pier 1 Imports Posts Wider Q3 Loss
category PIR , Markets , CTIB , and 14 more.
from Benzinga
Here's Why Apellis Pharmaceuticals Stock Jumped as Much as 40.7% Today
category APLS , ALXN , Market News
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]